Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

HALO

HALOZYME THERAPEUTICS, INC.

CIK 0001159036 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$108.17
↑ 2.05 (1.93%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Technicals; Risks: Options

Key stats

Market Cap
$12.28B
P/E Ratio
29.68
EPS
2.64
Dividend Yield
Not covered
52W Position
99%
Beta
0.55

Valuation multiples

Fwd P/E
13.39
PEG
-2.50
P/B
85.53
P/S
7.38
EV/Revenue
8.57
ROE
288.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 99%
$61.23$108.49

Latest Financials

2025-12-31 FY
Revenue
$1.40B
Net Income
$316.89M
Total Assets
$2.53B
Free Cash Flow
$644.59M

Recent news